As previously announced, Merz expects to cause its acquisition subsidiary Vine Acquisition Corp. to merge with and into BioForm Medical on February 19, 2010, with BioForm Medical surviving the ...

Merz North America announced today it has expanded its aesthetic portfolio through the acquisition of ON Light Sciences, Inc. – a U.S. medical device ...

Following news of the acquisition of BioForm Medical, Inc. earlier this year, Merz Aesthetics, the new business unit of Merz Pharma Group, makes its debut at the prestigious American ...

Merz Pharma has elected not to raise its $385m offer for dermatology specialist Obagi Medical Products, clearing the way for a takeover by rival Valeant Pharmaceuticals. Merz made an offer for Obagi ...

Nasdaq listed medical aesthetics company, BioForm Medical, Inc (BFRM) announced that its Board of Directors had unanimously accepted a cash offer of US$5.45 ...

Merz Pharma Group recently announced that it was reorganizing into three independently operating businesses: medical aesthetics, therapeutics and consumer care.

CHARLOTTE, N.C., Dec. 10, 2018 /PRNewswire/ -- MedShift, a leader in aesthetic medical equipment and technology, is excited to announce a five-year long strategic partnership with Merz North America.

CLEVELAND, Oct. 19, 2023 /PRNewswire/ -- VIO Med Spa and Merz Aesthetics hosted an exclusive event featuring renowned music sensation Machine Gun Kelly after the Forbes 30 Under 30 Concert ...

Merz North America is a specialty health care company in Greensboro that develops and commercializes treatments in aesthetics, dermatology and neurosciences in the U.S. and Canada.

(Reuters) - Germany's Merz Pharma Group withdrew its offer for U.S. cosmetic products maker Obagi Medical Products Inc , after rival bidder Canada's Valeant Pharmaceuticals International Inc ...

German aesthetic player Merz has invested in recently announced company Cytrellis Biosystems. The Boston-based startup is developing aesthetic medical devices to remove sagging skin without ...

Nasdaq listed medical aesthetics company, BioForm Medical, Inc (BFRM) announced that its Board of Directors had unanimously accepted a cash offer of US$5.45 per share from German pharmaceutical ...